February 2020
Volume 15 Issue 2 |
|
|
|
|
Features
Synthetic biology can help researchers circumvent the challenges of traditional methods of antibody generation.
/ read more /
Concentrating on symptoms instead of root causes locks teams into a corrective, rather than precautionary, approach.
/ read more /
|
|
|
Subscribe
Subscribers can enjoy each full issue of Pharmaceutical Technology in print or via the PharmTech app.
subscription offers |
 |
|
 |
|
News
The license gives Daiichi Sankyo access to ERS Genomics’ genome-editing technology for internal R&D initiatives
/ read more /
Otsuka will use PhoreMost’s phenotypic screening platform to identify new targets for drug development, with a focus on gene therapy.
/ read more /
The new 1800-m2 building houses more than 50 employees and features non-GMP laboratory space and a GMP analytical laboratory.
/ read more /
|
|
|
| |
New Technology
The partners will collaborate on developing scale-up chip-based technology to enable commercial-scale production of a third-generation DNA synthesis platform.
/ read more /
The company’s new Milliflex Oasis System provides enhanced result reliability, increased productivity, and advanced traceability.
/ read more /
The system is the first SPR device to combine digital microfluidics, artificial intelligence, and nanotechnology into one instrument.
/ read more /
RedySmart mass flow meters and controllers and RedyCompact flow meters and regulators use micro-electromechanical systems (MEMS) technology and complementary metal oxide semiconductor sensors to improve OEM applications and replace antiquated rotameters.
/ read more /
The evaporators are designed to boost evaporation and lyophilization results while remaining environmentally friendly and maintaining high-throughput and speed.
/ read more /
|
 |
| |
